学会発表一覧
HepDART 2015でのPXBマウスおよびPXB-cells関連研究発表のご案内
2015/12/16
2015年 12月6日(日)～12月10日(木)にGrand Wailea(Maui, Hawaii)にて開催されましたHepDART 2015
にてPXBマウスおよびPXB-cells関連研究発表がありましたので、ご案内申し上げます。
Oral Presentation
Session Title: The Tide has shifted Toward HBV Cure and Treatment for NASH
“Cyclophilin Inhibitors and Their Potential as Therapeutics for the Treatment of HBV”
Dr. Michael Sofia, Arbutus Biopharma Corporation, USA
“Preclinical and Clinical Profile of NVR 3-778, a First-In-Class HBV Core Inhibitor for the Treatment of Chronic Hepatitis B”
Dr. Osvaldo Flores, Novira Therapeutics, USA
“RG-101, a Novel microRNA Therapeutic to Target the Host Factor of HCV”
Dr. Paul Grint, Regulus Therapeutics, USA
Poster Presentation
Session Title: Next Generation of Anti-Hepatitis Inhibitors
Abstract #110
“4′-Modified Nucleoside Analogs: Potent Inhibitors Active against Entecavir Resistant Hepatitis B Virus (HBV) and their Structure-Activity Relationship”
Dr. Hiroaki Mitsuya, Kumamoto University, Japan
Abstract #111
“BB-HB-331, a DNA-Directed RNA Interference Agent (ddRNAi) for the Treatment of Subjects Infected with the Hepatitis B Virus (HBV), Can Effectively Suppress HBV in a Primary Hepatocyte Model”
Dr. David Suhy, Benitec Biopharma, USA
